Tg(Erv4-cre/ERT2*)657Slp
Transgene Detail
|
Symbol: |
Tg(Erv4-cre/ERT2*)657Slp |
Name: |
transgene insertion 657, Samuel L Pfaff |
MGI ID: |
MGI:5431581 |
Synonyms: |
2C::ERT2-Cre-ERT2, Tg(MuERV-L-ERT2-Cre-ERT2)657Slp |
Transgene: |
Tg(Erv4-cre/ERT2*)657Slp Location: unknown
|
Alliance: |
Tg(Erv4-cre/ERT2*)657Slp page
|
|
Strain of Origin: |
BALB/c and C57BL/6
|
|
Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Tg(Erv4-cre/ERT2*)657Slp expression driven by
1 gene
Transgene expression driven by:
Organism |
Driver Gene |
Note |
virus |
Erv4 |
|
|
|
|
Mutation details: The 5' LTR of murine endogenous retrovirus with leucine tRNA primer (MuERV-L; MERVL; Erv4) and the primer binding site drive expression of tamoxifen-inducible Cre recombinase (2C::ERT2-Cre-ERT2). Two flanking ERT2 segments were inserted to make Cre activation less leaky. The transgenic vector was injected into CB6 (BALB/c and C57BL/6) embryos and the resultant strain was subsequently maintained on the same mixed genetic background by the donating laboratory. This is founder line 657.
(J:186302)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Erv4
(virus)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:186302 Macfarlan TS, et al., Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature. 2012 Jul 5;487(7405):57-63 |
All: |
1 reference(s) |
|